Related Experiment Video
Updated: Jun 23, 2026
Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Testing vaccines in pediatric research subjects
Robert M Jacobson1, Inna G Ovsyannikova, Gregory A Poland
1Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, United States. jacobson.robert@mayo.edu
Insights
Navigating pediatric vaccine trials requires understanding ethical regulations and parental roles. Innovative methods and parental engagement are key to successful child research, addressing challenges like placebo use and compensation.
Area of Science:
- Pediatric vaccine research
- Human subjects research ethics
- Clinical trial design
Background:
- Historical challenges in pediatric vaccine research informed current human subject research regulations.
- Regulations permit pediatric studies but include specific restrictions impacting vaccine trial design.
- Ethical considerations, such as placebo use and parental consent, present unique challenges in pediatric research.
Purpose of the Study:
- To explore ethical considerations and regulatory implications for pediatric vaccine trials.
- To identify strategies for overcoming challenges in pediatric vaccine research, including placebo use and parental engagement.
- To examine the role of parental attitudes and remuneration in the success of pediatric vaccine studies.
Main Methods:
- Review of past difficulties and their influence on modern regulations for pediatric research.
- Analysis of ethical issues, including placebo use and parental permission, in vaccine trials.
- Examination of studies on parental attitudes towards pediatric research participation and remuneration.
Main Results:
- Modern regulations allow pediatric research with specific restrictions, affecting vaccine trial design.
- Alternatives to placebos exist that maintain trial integrity and secure parental support.
- Parental involvement in recruitment, retention, and data acquisition is crucial; their attitudes influence participation.
- Variations in practice exist regarding child research volunteer remuneration.
Conclusions:
- Understanding regulatory restrictions, placebo alternatives, parental attitudes, and remuneration is vital for effective pediatric vaccine trials.
- Ethical issues in pediatric vaccine research are significant but manageable with appropriate strategies.
- Engaging parents as active partners enhances the design and execution of pediatric vaccine studies.
Abstract:
Past difficulties encountered in pediatric vaccine research have positively influenced the development of modern regulations of human subjects' research. These regulations permit pediatric research but impose special restrictions on the types of studies to which children may participate, and these restrictions have important implications for modern vaccine trials. These ethical issues pose real but surmountable concerns. Considerations also include the use of placebos, critical for trial design but an impediment to parental permission. Recent pediatric vaccine studies illustrate practical alternatives to placebos that preserve allocation concealment and blinding yet obtain parental support. Vaccine researchers must consider the role parents play, not just in giving formal permission for their children's participation, but also for their roles in active recruitment, successful retention, and data acquisition. Studies of parents' attitudes do identify consistencies among motivating forces that drive parents to participate or refuse their children's participation. These studies should influence how we design and execute pediatric vaccine trials. Finally, ethical considerations and current regulations raise certain issues concerning the remuneration of the research volunteer when that volunteer is a child. The published literature illustrates wide variation in practice. Better understanding of the restrictions in pediatric research, the use of placebos, the attitude of parents, and the concerns with remuneration can better equip the vaccine researcher in pursuing successful studies in children.
